Learning Objectives
At the conclusion of the series, participants should be able to:
Session Learning objectivesAt the conclusion of this session, participants should be able to:
FINANCIAL DISCLOSURES
Planning Committee
Monica Giovanni, MS, CGC
Geisinger Health System, Brookline, MA
Nothing to disclose
Liming Bao, MD, PhD, FACMG
Dartmouth-Hitchcock Medical Center
Christian Schaaf, MD, PhD, FACMG
Baylor College of Medicine and Jan & Dan Duncan Neurological Research Institute, Houston, TX
Staff - American College of Medical Genetics and Genomics
The following have nothing to disclose.
Jane Radford, MHA, CHCP
Claudia Barnett
Michael Watson, PhD, FACMG
Contributors: HudsonAlpha Institute for Biotechnology
Michelle Amaral, Post-doctoral Researcher
Michelle Thompson, Senior Scientist
Candice Finnila, Senior Scientist
Presenters and Disclosures
Kevin M. Bowling, PhD, Senior Scientist, HudsonAlpha Institute for Biotechnology
Whitley V. Kelley, CGC, Genetic Counselor, HudsonAlpha Institute for Biotechnology
Gregory M. Cooper, PhD, Faculty Investigator, HudsonAlpha Institute for BiotechnologyMartina Bebin, MD, MPA, Professor, Neurology, University of Alabama at Birmingham
Dr. E. Martina Bebin will be discussing the following off-label disclosure: Riluzole
© 2023 American College of Medical Genetics and Genomics. All rights reserved.